Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06240806
Other study ID # 23-061
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2023
Est. completion date January 10, 2024

Study information

Verified date January 2024
Source British University In Egypt
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Xerostomia causes many clinical problems, including oral infections, speech difficulties, and impaired chewing and swallowing of food thus may affect the individual's quality of life, therefore this study aimed to evaluate the clinical effectiveness of Manuka honey mouth rinse using the subjective dry mouth score, and patient satisfaction as primary objectives and to assess the effect of Manuka honey on the salivary flow rate, and objective dry mouth score as secondary objectives.


Description:

Xerostomia has a variety of possible etiological factors; it is generally classified as having primary and secondary causes. Primary causes comprise conditions that directly affect the salivary glands and induce xerostomia like, Sjogren's syndrome, diabetes mellitus type 1 and 2, thyroid disease, adrenal pathology, renal or hepatic diseases, hepatitis C virus infection, and HIV disease. Secondary causes of xerostomia include the side-effects of radiation therapy or chemotherapy, rheumatoid arthritis, scleroderma, mixed connective tissues diseases, systemic lupus erythematous, graft versus host disease, anorexia, alcohol and smoking and commonly prescribed drugs (>500 medications reportedly cause dry mouth). The most common medications causing hyposalivation are those with anticholinergic activity, sympathomimetic, and benzodiazepines. The risk of xerostomia increases with the synergistic effects of xerogenic medications, multiple medications, higher doses of medication, and the duration of the medication. Honey was found to have several benefits as an alternative medicine, it has been used as a natural medicine for more than 2000 years, mainly for wound healing. Though there are many varieties of honey, only some of them e.g. Manuka honey and Malaysian Tualang honey, have been studied in detail for their medicinal properties. Manuka honey is a monofloral honey, produced from the nectar of flowers of Manuka tree. This variety is produced from the Apis mellifera honey bees, using New Zealand Manuka plants producing specific floral-variety named as Leptospermum scoparium. The composition of Manuka honey consists of carbohydrates, minerals, proteins, fatty acids, phenolic and flavonoid compounds. Although such compounds are found in other types of honey, other unique features also occur in Manuka honey, such as an unusually high level of methylglyoxal (MGO) formed from dihydroxyacetone (DHA) which correlates with antibacterial activity.Manuka honey shows antioxidant and anticancer properties, which are considered due to its constituents-phytochemicals working as active bio-compounds.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date January 10, 2024
Est. primary completion date December 15, 2023
Accepts healthy volunteers No
Gender All
Age group 66 Years and older
Eligibility Inclusion Criteria: - - Both genders, aged above 65 years. - All patients must have complaint of xerostomia. - Patients must be able to make reliable decision or communications. Exclusion Criteria: - - Smoking, Alcohol. - Patient with history of any serious illness as malignancy. - Patients with any autoimmune disease. - Vulnerable groups such as pregnant females, prisoners, mentally and physically handicapped individuals. - Known hypersensitivity or severe adverse effects to the treatment drugs or to any ingredient of their preparation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Manuka Honey
Manuka honey will be topically applied to the oral mucosa as oral rinse based on the Biswal et al., 2003 administration protocol.
Saline mouthwash
Saline mouthwash will be used 3 times per day for one month

Locations

Country Name City State
Egypt The British University in Egypt Cairo

Sponsors (1)

Lead Sponsor Collaborator
British University In Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in subjective dry mouth score changes in subjective dry mouth score [Time frame: baseline, 2 weeks, and 4 weeks] after manuka honey mouth rinse use higher number scores mean worse diagnosis while lower values mean better prognosis one month
Secondary Changes in objective dry mouth score changes in objective dry mouth score [Time frame: baseline, 2 weeks, and 4 weeks] after manuka honey mouth rinse use higher number scores mean worse diagnosis while lower values mean better prognosis one month
Secondary Increase in Unstimulated Salivary flow rate (ml/min) Eating and talking were prohibited during the time of collection. Unstimulated whole saliva was collected for 5 min by spitting method. The collection will be timed, so that flow rate (mL/min) could be measured As the salivary flow rates increased it means improvement one month
Secondary Changes in salivary potential of hydrogen ion (pH) following saliva collection, pH was measured immediately using the narrow-range pH strip system (Merck). One drop of the collected saliva was placed on the test strip and its color change reflected the pH of the saliva.
As salivary pH increased it means improvement
one month
See also
  Status Clinical Trial Phase
Completed NCT04914208 - Effect of Wearing Face Masks on Salivary Parameters and Halitosis N/A
Completed NCT00601874 - Bioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting Conditions N/A
Completed NCT00601211 - Bioequivalency Study of 5 mg Piolocarpine Tablets Under Fed Conditions N/A
Completed NCT04152642 - A Pilot Study to Assess Dry Mouth Relief After Using an Experimental Mouth Rinse N/A
Completed NCT03215251 - Effectiveness of an Intervention Bundle on Thirst Intensity and Dry Mouth Among Patients in ICUs N/A
Completed NCT04632004 - Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health N/A
Completed NCT05640362 - Efficacy of Natural Enzymes Mouthwash: a Randomised Controlled Trial N/A
Not yet recruiting NCT06412627 - The Effect of Intervention About Dry Mouth and Thirst in Patients With Endotracheal Tube N/A
Completed NCT04986501 - Clinical Evaluation of MucoPEG™ for Xerostomia N/A
Completed NCT04189081 - Improvement of Dry Mouth Sufferers After Using an Experimental Dry Mouth Rinse Compared to a Water Control N/A
Completed NCT05871580 - Effect to the Photobiomodulation in the Burning Mouth Syndrome N/A
Completed NCT06258603 - Oral Care of Intubated Intensive Care Patient N/A
Completed NCT01647737 - Green Tea Lozenges for the Management of Dry Mouth Phase 1/Phase 2
Completed NCT01737307 - Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy Phase 2
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Completed NCT03035825 - Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients N/A
Recruiting NCT05964959 - A Mouth Education Program for Dry Mouth N/A
Withdrawn NCT02123147 - Examining the Immunological Process of Autoimmune Patients N/A
Completed NCT01885065 - Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients N/A
Completed NCT03281486 - "Hyaluronan" Formulation for Type 2 Diabetic Patients With Dry Mouth N/A